📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-14 15:24
538 analysed today
FollowTelegram
538
Today
149,939
All-time analysed
42,983
Positive
6,669
Negative
91,579
Neutral
8,640
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
Yash Chemex Q1 Revenue Drops 45% YoY; Appoints Statutory Auditor for 5-Year Term
Yash Chemex reported a sharp 45.2% YoY decline in standalone revenue from operations to ₹9.71 Cr for Q1 FY27, down from ₹17.75 Cr. Despite the revenue contraction, net profit increased 63% YoY to ₹0.49 Cr, largely supported by a significant spike in 'Other Income' to ₹0.56 Cr (vs ₹0.016 Cr YoY). The company also proposed the appointment of M/s TRS & Associates as Statutory Auditors for a five-year term (FY27-FY31), pending shareholder approval at the upcoming AGM on September 30, 2026.
Confidence: HIGH
What changedThe company has reported its Q1 FY27 financial results and initiated a change in its statutory and internal auditing firms.
Why it mattersFor a micro-cap chemical trader with thin margins (TTM OPM 0.8%), high revenue volatility is a significant risk factor. The appointment of a new auditor for a 5-year term provides long-term regulatory oversight continuity.
Q1 Revenue from Operations: ₹9.71 CrRevenue Growth (YoY): -45.2%Q1 Net Profit: ₹0.49 CrOther Income: ₹0.56 CrStatutory Auditor Tenure: 5 Years
📅 Short termThe stock may face pressure due to the substantial drop in top-line performance, although the improved net profit figure might provide some support.
📈 Long termLimited structural impact; the company remains a small-scale player in the chemical trading industry with very low operating margins and high sensitivity to procurement costs.
⚠ Risk flags
- Significant YoY revenue decline (45%)
- Profitability heavily dependent on non-operational 'Other Income'
- Extremely thin operating margins (TTM OPM < 1%)
Key Highlights
Revenue from operations fell 45.2% YoY to ₹9.71 Cr in Q1 FY27 from ₹17.75 Cr in Q1 FY26.
Net profit rose to ₹0.49 Cr in Q1 FY27, up from ₹0.30 Cr in the corresponding quarter last year.
Other income contributed ₹56.29 Lakhs to the bottom line, exceeding the total net profit for the quarter.
M/s TRS & Associates appointed as Statutory Auditors for a 5-year tenure until the 2031 AGM.
M/s N. H. Desai & Co. appointed as Internal Auditor for the financial year ending March 31, 2027.
👀 What to Watch
Investors should monitor the sustainability of revenue, as the sharp decline suggests a potential loss in trading volumes or pricing power. The reliance on 'Other Income' to drive profit growth this quarter warrants caution regarding core operational performance.
Yash Chemex Q1 Revenue Drops 45% to ₹9.71 Cr; Net Profit Rises to ₹0.49 Cr
Yash Chemex reported a sharp 45.3% YoY decline in revenue from operations to ₹9.71 Cr for Q1 FY27, down from ₹17.75 Cr in the previous year. Despite the revenue contraction, net profit increased by 64% to ₹0.49 Cr, largely supported by a surge in 'Other Income' to ₹56.29 Lakhs (vs ₹1.59 Lakhs YoY). The company also announced the appointment of new internal auditors and proposed a 5-year term for M/s TRS & Associates as statutory auditors.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results and initiated a transition in its auditing team, appointing new internal and statutory auditors.
Why it mattersFor a micro-cap chemical trader with thin operating margins (TTM OPM 0.8%), a 45% drop in quarterly revenue indicates a significant scale contraction that could impact long-term viability if not reversed.
Q1 Revenue: ₹9.71 CrRevenue Growth (YoY): -45.3%Q1 Net Profit: ₹0.49 CrOther Income: ₹56.29 LakhsQ1 Revenue vs TTM Revenue: 6.7%
📅 Short termThe stock may face pressure due to the substantial revenue miss, although the improved net profit and other comprehensive income might provide some support.
📈 Long termLimited; the company operates in a low-margin trading business and the current results show high volatility in top-line performance.
⚠ Risk flags
- Significant revenue contraction
- High reliance on 'Other Income' for profitability
- Micro-cap liquidity risks
Key Highlights
Revenue from operations fell significantly to ₹9.71 Cr from ₹17.75 Cr in Q1 FY26.
Net profit improved to ₹0.49 Cr compared to ₹0.30 Cr in the same quarter last year.
Other Income contributed ₹56.29 Lakhs to the bottom line, a massive jump from ₹1.59 Lakhs YoY.
Total Comprehensive Income stood at ₹1.53 Cr, aided by ₹1.04 Cr in other comprehensive items.
Proposed appointment of M/s TRS & Associates as Statutory Auditors for a 5-year term (FY27-FY31).
👀 What to Watch
Investors should monitor the sustainability of the company's revenue, as the current quarter's run rate is significantly below the TTM average. Watch for the upcoming AGM on September 30, 2026, for management commentary on the revenue decline.
Yash Chemex Q1 PAT Rises 64% to ₹0.49 Cr Despite 45% Revenue Contraction
Yash Chemex reported a challenging Q1 FY27 with revenue from operations falling 45.2% YoY to ₹9.71 Cr, significantly below its TTM quarterly average. Despite the top-line slump, Net Profit grew 64% YoY to ₹0.49 Cr, primarily driven by a surge in 'Other Income' to ₹0.56 Cr, which accounted for 86% of the Profit Before Tax. The company also announced the appointment of new internal and statutory auditors and scheduled its 20th AGM for September 30, 2026.
Confidence: HIGH
What changedThe company experienced a significant scale-down in its trading operations during the quarter while improving net profitability through non-core income and reduced purchase costs.
Why it mattersFor a micro-cap chemical trader with thin margins (OPM 0.8%), maintaining revenue scale is critical for absorbing fixed costs; the current revenue run rate is well below the FY26 average.
Revenue (Q1 FY27): ₹9.71 CrNet Profit (Q1 FY27): ₹0.49 CrOther Income: ₹0.56 CrRevenue vs TTM Quarterly Avg: 27.0%YoY Revenue Growth: -45.2%
📅 Short termThe stock may face pressure due to the substantial drop in operational revenue, although the reported profit growth might provide a technical floor.
📈 Long termLimited structural significance; the company remains a small-scale trader sensitive to chemical price cycles and volume fluctuations.
⚠ Risk flags
- Significant revenue contraction
- High dependence on non-operating income for profits
- Low operating margins inherent to trading business
Key Highlights
Revenue from operations declined sharply to ₹9.71 Cr from ₹17.75 Cr in the year-ago quarter.
Net Profit increased to ₹0.49 Cr compared to ₹0.30 Cr in Q1 FY26.
Other Income rose significantly to ₹56.29 Lakhs from just ₹1.59 Lakhs YoY.
Total Comprehensive Income reached ₹1.53 Cr, boosted by ₹1.04 Cr in other comprehensive items.
Purchase of stock-in-trade reduced by 47% YoY to ₹9.37 Cr, reflecting lower trading volumes.
👀 What to Watch
Investors should monitor if the sharp revenue decline is a temporary cyclical downturn in chemical trading or a structural loss of volume. The high reliance on non-operating income to sustain profitability this quarter is a key area of concern.
Yash Chemex Q1 Profit Rises 21% YoY to ₹1.04 Cr; Manufacturing Revenue Grows 5x
Yash Chemex reported a consolidated net profit of ₹1.04 Cr for Q1 FY27, a 21% increase from ₹0.86 Cr in the same quarter last year and a recovery from the ₹0.44 Cr loss in the preceding quarter. Total income fell 38.8% YoY to ₹18.58 Cr, primarily due to a sharp decline in the trading segment. However, the manufacturing segment saw significant growth, contributing ₹5.61 Cr to revenue compared to just ₹1.13 Cr a year ago. The board also proposed the appointment of M/s TRS & Associates as statutory auditors for a five-year term starting FY27.
Confidence: HIGH
What changedThe company has reported its Q1 FY27 financial results and initiated a change in its statutory and internal audit firms.
Why it mattersThe results indicate a strategic shift in the business mix from low-margin trading to manufacturing, which has improved profitability despite a lower overall top-line. This is critical for a company with historically low operating margins (0.8% TTM).
Q1 Net Profit: ₹1.04 CrQ1 Total Income: ₹18.58 CrManufacturing Revenue Growth: 396%Trading Revenue Decline: 59.6%Q1 EPS: ₹0.75
📅 Short termThe stock may see positive sentiment due to the profit turnaround from the previous quarter's loss and the expansion of the manufacturing base.
📈 Long termIf the company continues to scale its manufacturing segment, it could lead to structural margin expansion and a potential re-rating of the business from a pure trader to a manufacturer.
⚠ Risk flags
- Significant decline in core trading revenue
- Small scale of operations (Micro-cap)
- High volatility in quarterly income
Key Highlights
Consolidated Net Profit increased to ₹1.04 Cr from ₹0.86 Cr YoY, representing a 21% growth.
Total Income declined by 38.8% YoY to ₹18.58 Cr from ₹30.38 Cr in the year-ago period.
Manufacturing segment revenue surged to ₹5.61 Cr from ₹1.13 Cr YoY, now contributing ~30% of total revenue.
Trading segment revenue dropped significantly to ₹11.83 Cr from ₹29.32 Cr YoY.
Proposed appointment of M/s TRS & Associates as Statutory Auditors for a 5-year term (FY27-FY31).
👀 What to Watch
Investors should monitor the sustainability of the manufacturing segment's growth, as it offers higher margins than the volatile trading business. Watch for shareholder approval of the new auditors at the upcoming AGM on September 30, 2026.
